HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Selvakumar Selected Research

Antitubercular Agents

7/2012Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Selvakumar Research Topics

Disease

13Tuberculosis (Tuberculoses)
01/2014 - 03/2003
6Pulmonary Tuberculosis
06/2013 - 08/2002
3Extensively Drug-Resistant Tuberculosis
06/2013 - 10/2011
1Infections
09/2008
1Cough
03/2003

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
06/2013 - 03/2003
5Rifampin (Rifampicin)FDA LinkGeneric
07/2012 - 07/2003
4AcidsIBA
10/2012 - 03/2003
2cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2014 - 10/2006
2Isoniazid (Ftivazide)FDA LinkGeneric
07/2012 - 01/2006
1Ethionamide (Trecator-SC)FDA Link
06/2013
1PyrazinamideFDA LinkGeneric
07/2012
1Ethambutol (Myambutol)FDA LinkGeneric
07/2012
1Antitubercular AgentsIBA
07/2012
1Cetrimonium (CTAB)IBA
02/2012
1Ofloxacin (Ofloxacine)FDA LinkGeneric
10/2011
1Oxazolidinones (2 Oxazolidone)IBA
09/2008
1Streptomycin (Streptomycin Sulfate)FDA Link
01/2006
1ChloridesIBA
01/2003
1Sodium ChlorideFDA LinkGeneric
01/2003
1SolutionsIBA
01/2003
1Phenol (Carbolic Acid)FDA Link
08/2002
1Ammonium SulfateIBA
08/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2007 - 04/2007